Srikripa Devarakonda
Stock Analyst at Truist Financial
(4.94)
# 158
Out of 4,673 analysts
510
Total ratings
64.4%
Success rate
29.8%
Average return
Main Sectors:
Stocks Rated by Srikripa Devarakonda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CORT Corcept Therapeutics | Initiated Coverage: Buy | $164 | $122.25 | +34.15% | 1 | Aug 18, 2026 | |
| OABI OmniAb | Maintained: Buy | n/a | $4.33 | - | 9 | Aug 18, 2026 | |
| SEPN Septerna | Maintained: Buy | $43 → $59 | $40.00 | +47.50% | 7 | Aug 13, 2026 | |
| CYTK Cytokinetics | Maintained: Buy | $112 | $76.84 | +45.76% | 39 | Aug 11, 2026 | |
| LLY Eli Lilly and Company | Maintained: Buy | $1,376 | $1,255.40 | +9.61% | 38 | Aug 11, 2026 | |
| ABCL AbCellera Biologics | Reiterated: Buy | $12 → $30 | $11.32 | +165.02% | 13 | Aug 11, 2026 | |
| PTGX Protagonist Therapeutics | Maintained: Buy | $170 | $154.32 | +10.16% | 24 | Aug 10, 2026 | |
| ARVN Arvinas | Rated: Hold | $10 → $8.68 | $9.37 | -7.31% | 16 | Aug 10, 2026 | |
| MBX MBX Biosciences | Maintained: Buy | $88 | $66.33 | +32.67% | 11 | Aug 10, 2026 | |
| SRRK Scholar Rock Holding | Reiterated: Buy | n/a | $56.50 | - | 31 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $27.87 | - | 4 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $67.01 | +4.46% | 22 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $709 | $516.74 | +37.21% | 15 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $127.81 | - | 37 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $3.11 | - | 4 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.02 | - | 1 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $4.68 | +177.78% | 5 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $17 | $9.55 | +78.01% | 10 | Jul 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $136 | $119.80 | +13.52% | 23 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $44.18 | - | 34 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $13.16 | - | 1 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $11.03 | - | 21 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.58 | - | 6 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $439.33 | - | 15 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $139 → $214 | $125.77 | +70.15% | 2 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $26.72 | -13.92% | 15 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $812 | $834.04 | -2.64% | 14 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $84 | $93.02 | -9.70% | 1 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.42 | n/a | 8 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $142 | $216.78 | n/a | 12 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.37 | n/a | 7 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $152.55 | n/a | 8 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $28.07 | n/a | 10 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $264.96 | n/a | 7 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 15 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.52 | n/a | 3 | Dec 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $76.82 | n/a | 1 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $15 | $6.89 | n/a | 13 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $40 → $38 | $0.000001 | n/a | 7 | Mar 20, 2023 |
Corcept Therapeutics
Aug 18, 2026
Initiated Coverage: Buy
Price Target: $164
Current: $122.25
Upside: +34.15%
OmniAb
Aug 18, 2026
Maintained: Buy
Price Target: n/a
Current: $4.33
Upside: -
Septerna
Aug 13, 2026
Maintained: Buy
Price Target: $43 → $59
Current: $40.00
Upside: +47.50%
Cytokinetics
Aug 11, 2026
Maintained: Buy
Price Target: $112
Current: $76.84
Upside: +45.76%
Eli Lilly and Company
Aug 11, 2026
Maintained: Buy
Price Target: $1,376
Current: $1,255.40
Upside: +9.61%
AbCellera Biologics
Aug 11, 2026
Reiterated: Buy
Price Target: $12 → $30
Current: $11.32
Upside: +165.02%
Protagonist Therapeutics
Aug 10, 2026
Maintained: Buy
Price Target: $170
Current: $154.32
Upside: +10.16%
Arvinas
Aug 10, 2026
Rated: Hold
Price Target: $10 → $8.68
Current: $9.37
Upside: -7.31%
MBX Biosciences
Aug 10, 2026
Maintained: Buy
Price Target: $88
Current: $66.33
Upside: +32.67%
Scholar Rock Holding
Aug 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $56.50
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $27.87
Upside: -
Jul 31, 2026
Reiterated: Buy
Price Target: $70
Current: $67.01
Upside: +4.46%
Jul 31, 2026
Reiterated: Buy
Price Target: $709
Current: $516.74
Upside: +37.21%
Jul 29, 2026
Reiterated: Hold
Price Target: n/a
Current: $127.81
Upside: -
Jul 29, 2026
Maintained: Buy
Price Target: n/a
Current: $3.11
Upside: -
Jul 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.02
Upside: -
Jul 27, 2026
Reiterated: Buy
Price Target: $13
Current: $4.68
Upside: +177.78%
Jul 2, 2026
Reiterated: Buy
Price Target: $11 → $17
Current: $9.55
Upside: +78.01%
Jun 29, 2026
Rated: Buy
Price Target: $136
Current: $119.80
Upside: +13.52%
Jun 17, 2026
Maintained: Buy
Price Target: n/a
Current: $44.18
Upside: -
Jun 8, 2026
Reiterated: Hold
Price Target: n/a
Current: $13.16
Upside: -
May 15, 2026
Maintained: Buy
Price Target: n/a
Current: $11.03
Upside: -
Mar 23, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.58
Upside: -
Nov 5, 2025
Maintained: Hold
Price Target: n/a
Current: $439.33
Upside: -
Nov 3, 2025
Reiterated: Buy
Price Target: $139 → $214
Current: $125.77
Upside: +70.15%
Oct 30, 2025
Reiterated: Buy
Price Target: $23
Current: $26.72
Upside: -13.92%
Oct 29, 2025
Reiterated: Buy
Price Target: $812
Current: $834.04
Upside: -2.64%
Oct 10, 2025
Reiterated: Buy
Price Target: $84
Current: $93.02
Upside: -9.70%
Aug 4, 2025
Rated: Hold
Price Target: n/a
Current: $1.42
Upside: n/a
Jul 21, 2025
Downgraded: Hold
Price Target: $142
Current: $216.78
Upside: n/a
Jul 9, 2025
Rated: Hold
Price Target: n/a
Current: $1.37
Upside: n/a
Feb 24, 2025
Rated: Hold
Price Target: n/a
Current: $152.55
Upside: n/a
Feb 24, 2025
Rated: Hold
Price Target: n/a
Current: $28.07
Upside: n/a
Feb 24, 2025
Rated: Hold
Price Target: n/a
Current: $264.96
Upside: n/a
Jan 28, 2025
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Dec 23, 2024
Rated: Hold
Price Target: n/a
Current: $1.52
Upside: n/a
Nov 12, 2024
Reiterated: Buy
Price Target: n/a
Current: $76.82
Upside: n/a
Oct 18, 2024
Rated: Buy
Price Target: $15
Current: $6.89
Upside: n/a
Mar 20, 2023
Downgraded: Hold
Price Target: $40 → $38
Current: $0.000001
Upside: n/a